187 related articles for article (PubMed ID: 25034063)
1. A functional variant in APOA5/A4/C3/A1 gene cluster contributes to elevated triglycerides and severity of CAD by interfering with microRNA 3201 binding efficiency.
Cui G; Li Z; Li R; Huang J; Wang H; Zhang L; Ding H; Wang DW
J Am Coll Cardiol; 2014 Jul; 64(3):267-77. PubMed ID: 25034063
[TBL] [Abstract][Full Text] [Related]
2. Identifying functional non-coding variants in APOA5/A4/C3/A1 gene cluster associated with coronary heart disease.
Cui G; Tian M; Hu S; Wang Y; Wang DW
J Mol Cell Cardiol; 2020 Jul; 144():54-62. PubMed ID: 32437778
[TBL] [Abstract][Full Text] [Related]
3. Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease.
van de Woestijne AP; van der Graaf Y; de Bakker PI; Asselbergs FW; Spiering W; Visseren FL;
PLoS One; 2014; 9(6):e101082. PubMed ID: 24979386
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide variances can account for loss of microRNA function: the emerging cross talk between genetics and epigenetics.
Li RK; Guo J
J Am Coll Cardiol; 2014 Jul; 64(3):278-80. PubMed ID: 25034064
[No Abstract] [Full Text] [Related]
5. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
[TBL] [Abstract][Full Text] [Related]
6. Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese.
Liu ZK; Hu M; Baum L; Thomas GN; Tomlinson B
Atherosclerosis; 2010 Feb; 208(2):427-32. PubMed ID: 19732897
[TBL] [Abstract][Full Text] [Related]
7. Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease.
Shanker J; Perumal G; Rao VS; Khadrinarasimhiah NB; John S; Hebbagodi S; Mukherjee M; Kakkar VV
Lipids Health Dis; 2008 Sep; 7():33. PubMed ID: 18801202
[TBL] [Abstract][Full Text] [Related]
8. Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
Wu Y; Yu Y; Zhao T; Wang S; Fu Y; Qi Y; Yang G; Yao W; Su Y; Ma Y; Shi J; Jiang J; Kou C
PLoS One; 2016; 11(1):e0147946. PubMed ID: 26824674
[TBL] [Abstract][Full Text] [Related]
9. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
Qi L; Liu S; Rifai N; Hunter D; Hu FB
Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
[TBL] [Abstract][Full Text] [Related]
10. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
[TBL] [Abstract][Full Text] [Related]
11. Mutation screening of the APOA5 gene in subjects with coronary artery disease.
Soufi M; Sattler AM; Kurt B; Schaefer JR
J Investig Med; 2012 Oct; 60(7):1015-9. PubMed ID: 22914599
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
Liu Y; Ordovas JM; Gao G; Province M; Straka RJ; Tsai MY; Lai CQ; Zhang K; Borecki I; Hixson JE; Allison DB; Arnett DK
Pharmacogenet Genomics; 2009 Feb; 19(2):161-9. PubMed ID: 19057464
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.
Yin RX; Li YY; Lai CQ
Lipids Health Dis; 2011 Aug; 10():140. PubMed ID: 21854571
[TBL] [Abstract][Full Text] [Related]
14. [Polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene in patients with coronary artery disease].
Bi N; Yan SK; Li GP; Yin ZN; Xue H; Wu G; Chen BS
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):116-21. PubMed ID: 15924804
[TBL] [Abstract][Full Text] [Related]
15. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.
Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH
Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622
[TBL] [Abstract][Full Text] [Related]
16. Effects of Polymorphisms in APOA4-APOA5-ZNF259-BUD13 Gene Cluster on Plasma Levels of Triglycerides and Risk of Coronary Heart Disease in a Chinese Han Population.
Fu Q; Tang X; Chen J; Su L; Zhang M; Wang L; Jing J; Zhou L
PLoS One; 2015; 10(9):e0138652. PubMed ID: 26397108
[TBL] [Abstract][Full Text] [Related]
17. [A novel gene in APOA1/C3/A4/A5 cluster: apolipoprotein A5].
Liu HK; Zhang SZ; Su ZG; Ma YX; Wang CT
Yi Chuan; 2004 Nov; 26(6):953-6. PubMed ID: 15640132
[TBL] [Abstract][Full Text] [Related]
18. SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.
Wright WT; Young IS; Nicholls DP; Patterson C; Lyttle K; Graham CA
Atherosclerosis; 2006 Apr; 185(2):353-60. PubMed ID: 16125709
[TBL] [Abstract][Full Text] [Related]
19. Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease.
Dai W; Zhang Z; Yao C; Zhao S
Lipids Health Dis; 2019 Dec; 18(1):220. PubMed ID: 31836003
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
